New aspects in the treatment of cervical cancer;Neue aspekte in der behandlung des zervixkarzinoms

Gynakologe

Volumn 37, Issue 10, 2004, Pages 886-892

  Schneider, A ^a   Kohler C ^b   Klemm, P ^b   Hertel, H ^b   Durst M ^b   Kaufmann, A M ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

AGO study; Immunotherapy; Laparoscopy; Sentinel lymph node; Trachelectomy

Indexed keywords

VIRUS ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; CLINICAL PRACTICE; DISEASE ASSOCIATION; EVALUATION; FERTILITY; HUMAN; HYSTERECTOMY; IMMUNOTHERAPY; LAPAROSCOPY; LYMPH NODE; LYMPHADENECTOMY; PAPILLOMA VIRUS; PREGNANCY; PROGNOSIS; SAFETY; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TUMOR CELL; UTERINE CERVIX CANCER;

EID: 11144331449     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-004-1591-y     Document Type: Article

References (23)

1. Belhocine T, Thille A, Fridman V et al. (2002) Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 87: 90-97
2. Bosch FX, Manos MM, Munoz N et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802
3. Chen LR Thomas EK, Hu SL, Hellstrom I, Hellstrom KE (1991) Human papillomavirus 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA 88: 110-114
4. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann L (1987) Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1: 251-256
5. Ferrara A, Nonn M, Sehr P et al. (2003) Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. J Cancer Res Clin Oncol 129: 521-530
6. Hertel H, Köhler C, Elhawary T, Michels W, Possover M, Schneider A (2002) Laparoscopic staging compared with imaging techniques in staging of advanced cervical cancer. Gynecol Oncol 87: 46-51
7. Hertel H, Köhler C, Michels W, Possover M, Tozzi R, Schneider A (2003) Laparoscopic assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol 90: 505-511
8. IARC (1995) Monograph on evaluation of carcinogenic risks to humans: human papillomaviruses, vol. 64. IARC, Lyon
9. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ (2000) Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87: 221-227
10. Kaufmann AM, Backsch C, Schneider A, Dürst M (2002) HPV induced cervical carcinogenesis: molecular basis and vaccine development. Zentralbl Gynäkol 124: 511-524
11. Kaufmann AM, Stern PL, Rankin EM et al. (2002) Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified HPV16 and 18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res 8: 3676-3685
12. Köhler C, Klemm P, Schau A, Possover M, Krause N, Tozzi R, Schneider A (2004) Introduction of transperitoneal lymphadenectomy in a gynecologic oncology centre: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies. Gynecol Oncol 95 (1): 52-56
13. Köhler C, Tozzi R, Possover M, Schneider A (2002) Explorative laparoscopy prior to exenterative surgery. Gynecol Oncol 86: 311-315
14. Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY (2003) Usefulness of (18) F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89: 73-76
15. Marchiole P, Buenerd A, Scoazec JY, Dargent D, Mathevet P (2004) Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 100: 2154-2159
16. Medema JR de Jong J, Peltenburg LT et al. (2001) Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 98: 11515-11520
17. Munoz N, Bosch FX, de Sanjose S et al. (1992) The causal link between human papillomavirus and invasive cervical cancer: a population based case-control study in Columbia and Spain. Int J Cancer 52: 743-749
18. Plante CME (2003) Combined laparoscopic and vaginal surgery in cervical cancer. J Gynecol Oncol 8: 97-107
19. Possover M, Stöber S, Plaul K, Schneider A (2000) Identification and preservation of the motoric innervation of the bladder in radical hysterctomy type III. Gynecol Oncol 79: 154-157
20. Ritz U, Momburg F, Pilch H, Maeurer MJ, Seliger B (2001) Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int J Oncol 19: 1211-1220
21. Schneider A, Hertel H (2004) Surgical and radiographic staging in patients with cervical cancer. Curr Opin Obstet Gynecol 16: 11-18
22. Walboomers JM, Jacobs MV, Manos MM et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
23. Malur S, Krause N, Köhler C, Schneider A (2001) Sentinel lymphnodedetection in patients with cervical cancer. Gynecol Oncol 80 (2): 254-257